The move paves the way for a global rollout, but the drugmaker did not provide key details in interim analysis of late-stage trials.
Read more here…
Source:https://www.washingtonpost.com/world/asia_pacific/coronavirus-vaccine-china-sinopharm/2020/12/30/1cc4be9e-4a62-11eb-97b6-4eb9f72ff46b_story.html?utm_source=rss&utm_medium=referral&utm_campaign=wp_world
Published on: Thu, 31 Dec 2020 02:14:00 EST
